tag chmp 
Drug Discovery World
DECEMBER 20, 2022
The first gene therapy for haemophilia B could soon be available to patients in Europe following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP). . Concerns about the high price tag have been raised in an article in Nature, particularly whether it will be affordable for low to middle-income countries. .
pharmaphorum
JULY 25, 2022
The CHMP has backed approval of Tecvayli for adults with relapsed and refractory multiple myeloma who have received at least three prior therapies – including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody – setting up a full approval in the coming weeks. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
FEBRUARY 9, 2021
Breyanzi will come with a price tag of USD 410,300 wholesale price, said the company, justifying it after taking into consideration several factors including medical and clinical value, patient value, and societal value. The nod came a few months after the CHMP opinionated positively for the same.
pharmaphorum
MARCH 27, 2022
The CHMP recommended conditional approval for Carvykti (ciltacabtagene autoleucel or cilta-cel) as a treatment for adults with relapsed and refractory multiple myeloma who have received at least three prior therapies and whose cancer is worsening. The post CHMP backs J&J’s myeloma CAR-T therapy Carvykti appeared first on.
The Pharma Data
MAY 4, 2021
With the MAA acceptance, the formal review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP) begins. The information contained on our website or any third-party website is not incorporated by reference into this earnings release. View source version on businesswire.com : [link]. Amy Rose 212.733.7410. Source link.
Expert insights. Personalized for you.
52 
Let's personalize your content